Autism Drug Push Stumbles as GSK Pulls Application

Federal health officials last fall touted a new treatment for autism: leucovorin, a derivative of Vitamin B9 commonly used during cancer treatment. But the drugmaker, GSK, this week asked the Food and Drug Administration to pull its application.

Related articles

You may also be interested in

Trump Moves to Weaken Coal Ash Rules

The Trump administration on Thursday proposed weakening rules for the disposal of ash produced by burning coal that can contain hazardous heavy metals and contaminate

Headline

Never Miss A Story

Get our Weekly recap with the latest news, articles and resources.
Cookie policy

We use our own and third party cookies to allow us to understand how the site is used and to support our marketing campaigns.